We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
July 27th, 2018, HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Sanofi to identify novel small molecule leads for targets of interest. In this collaboration, HitGen will apply its advanced technology pl
Chengdu, China,November 23rd 2017, HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Boehringer Ingelheim to identify novel small molecule leads for targets of interest to Boehringer Ingelheim.